📈 Stocks
Ionis Pharmaceuticals Shares Slide 13% Following Failed Phase 3 Drug Trial
(1 day ago)
Ionis Pharmaceuticals stock hit near 52-week lows after the Phase 3 trial for its cardiovascular drug pelacarsen failed to meet primary endpoints,…